← Back to Analyst Consensus 
COLL Buy
COLLEGIUM PHARMACEUTICAL, INC
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Sep 9, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 9, 2026 | Leerink Partners | initiate | — → Outperform | — | 50% |
| Aug 19, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 7, 2026 | Piper Sandler | reiterate | Neutral → Neutral | — | 54% |
| Aug 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 19, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Feb 26, 2026 | Needham | maintain | Buy → Buy | $54 | 50% |
| Jan 9, 2026 | Barclays | maintain | Overweight → Overweight | $56 | 53% |
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Jan 8, 2026 | Needham | maintain | Buy → Buy | $56 | 50% |
| Dec 9, 2025 | Barclays | initiate | — → Overweight | $58 | 53% |
| Nov 7, 2025 | Truist Securities | maintain | Buy → Buy | $48 | 54% |
| Nov 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $46 | 44% |
| Oct 28, 2025 | Needham | reiterate | Buy → Buy | $46 | 50% |
| May 9, 2025 | Piper Sandler | reiterate | Neutral → Neutral | $37 | 54% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $46 | 50% |
| Mar 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Feb 4, 2025 | Piper Sandler | maintain | Neutral → Neutral | $36 | 54% |
| Jan 10, 2025 | Needham | upgrade | Hold → Buy | $46 | 50% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Oct 11, 2024 | Piper Sandler | reiterate | Neutral → Neutral | $37 | 54% |
| Sep 5, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Aug 9, 2024 | Piper Sandler | reiterate | Neutral → Neutral | $37 | 54% |
| Aug 9, 2024 | Truist Securities | maintain | Buy → Buy | $42 | 54% |
| Aug 9, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Jul 30, 2024 | HC Wainwright & Co. | upgrade | Neutral → Buy | $47 | 44% |
| Jul 30, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Jun 7, 2024 | Jefferies | upgrade | Hold → Buy | $44 | 52% |
| May 10, 2024 | Needham | downgrade | Buy → Hold | $0 | 50% |
| May 10, 2024 | Piper Sandler | downgrade | Overweight → Neutral | $39 | 54% |
| Apr 11, 2024 | Needham | reiterate | Buy → Buy | $40 | 50% |
| Feb 26, 2024 | Truist Securities | maintain | Buy → Buy | $40 | 54% |
| Feb 23, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $39 | 54% |
| Feb 2, 2024 | Needham | reiterate | Buy → Buy | $40 | 50% |
| Jan 4, 2024 | Needham | maintain | Buy → Buy | $40 | 50% |
| Jan 4, 2024 | Truist Securities | maintain | Buy → Buy | $37 | 54% |
| Jan 4, 2024 | Jefferies | downgrade | Buy → Hold | $37 | 52% |
| Aug 25, 2023 | Needham | maintain | Buy → Buy | $36 | 50% |
| Aug 4, 2023 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 4, 2023 | Needham | reiterate | Buy → Buy | $35 | 50% |
| May 30, 2023 | Needham | reiterate | Buy → Buy | $35 | 50% |
| May 5, 2023 | Needham | reiterate | — → Buy | $35 | 50% |
| Apr 19, 2023 | Needham | reiterate | — → Buy | $35 | 50% |
| Feb 24, 2023 | Needham | reiterate | — → Buy | $35 | 50% |
| Feb 8, 2023 | Needham | reiterate | — → Buy | $35 | 50% |
| Jan 5, 2023 | Needham | maintain | — → Buy | $35 | 50% |
| Nov 4, 2022 | Needham | maintain | — → Buy | $34 | 50% |
| Aug 8, 2022 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
Price Target Trend
May 7, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days